ArsenalBio

South San Francisco, CA · Founded 2018 · Privately Held (backing)

Operator of a programmable cell therapy company intended to discover, develop, and commercialize curative immune cell therapies. ArsenalBio is based in South San Francisco, CA and was founded in 2018. Its last known valuation is $1.9 billion. It has raised $631 million.

Last price · $/share

—

Implied valuation

$1.9B

Total raised

$630.8M

Last round

—

How much has ArsenalBio raised?

$630.8Macross 0 recorded rounds

Free account

More of ArsenalBio with a free account

·The complete investor list: 24 names
·Watch ArsenalBio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

ArsenalBio investors

24 investors are on record for ArsenalBio, including SoftBank Investment Advisers, Kleiner Perkins, University of California and ARCH Venture Partners. By type, the record holds 4 venture capital firms and 2 family offices.

For fundraisers

Raising for a company like ArsenalBio?

24 investors have backed ArsenalBio.

See all 24 investors →

Frequently asked about ArsenalBio

How much has ArsenalBio raised?: ArsenalBio has raised $630.8M in total across 0 recorded funding rounds.